Correlation Between Kodiak Sciences and Abeona Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kodiak Sciences and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kodiak Sciences and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kodiak Sciences and Abeona Therapeutics, you can compare the effects of market volatilities on Kodiak Sciences and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kodiak Sciences with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kodiak Sciences and Abeona Therapeutics.

Diversification Opportunities for Kodiak Sciences and Abeona Therapeutics

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Kodiak and Abeona is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Kodiak Sciences and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Kodiak Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kodiak Sciences are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Kodiak Sciences i.e., Kodiak Sciences and Abeona Therapeutics go up and down completely randomly.

Pair Corralation between Kodiak Sciences and Abeona Therapeutics

Considering the 90-day investment horizon Kodiak Sciences is expected to generate 1.55 times more return on investment than Abeona Therapeutics. However, Kodiak Sciences is 1.55 times more volatile than Abeona Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Abeona Therapeutics is currently generating about 0.1 per unit of risk. If you would invest  324.00  in Kodiak Sciences on September 1, 2024 and sell it today you would earn a total of  343.00  from holding Kodiak Sciences or generate 105.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kodiak Sciences  vs.  Abeona Therapeutics

 Performance 
       Timeline  
Kodiak Sciences 

Risk-Adjusted Performance

32 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Kodiak Sciences are ranked lower than 32 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal basic indicators, Kodiak Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
Abeona Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abeona Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Abeona Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Kodiak Sciences and Abeona Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kodiak Sciences and Abeona Therapeutics

The main advantage of trading using opposite Kodiak Sciences and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kodiak Sciences position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.
The idea behind Kodiak Sciences and Abeona Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance